Icariin ameliorates the cuprizone-induced demyelination associated with antioxidation and anti-inflammation.

CPZ demyelination Icariin Microglia Nrf2/NF-κB signaling pathways Oxidative stress/inflammation

Journal

Inflammopharmacology
ISSN: 1568-5608
Titre abrégé: Inflammopharmacology
Pays: Switzerland
ID NLM: 9112626

Informations de publication

Date de publication:
04 Jan 2024
Historique:
received: 12 06 2023
accepted: 23 08 2023
medline: 5 1 2024
pubmed: 5 1 2024
entrez: 4 1 2024
Statut: aheadofprint

Résumé

The treatment of immunomodulation in multiple sclerosis (MS) can alleviate the severity and relapses. However, it cannot improve the neurological disability of patients due to a lack of myelin protection and regeneration. Therefore, remyelinating therapies may be one of the feasible strategies that can prevent axonal degeneration and restore neurological disability. Natural product icariin (ICA) is a flavonol compound extracted from epimedium flavonoids, which has neuroprotective effects in several models of neurological diseases. Here, we attempt to explore whether ICA has the potential to treat demyelination and its possible mechanisms of action using lipopolysaccharide-treated BV2 microglia, primary microglia, bone marrow-derived macrophages, and cuprizone-induced demyelination model. The indicators of oxidative stress and inflammatory response were evaluated using commercial kits. The results showed that ICA significantly reduced the levels of oxidative intermediates nitric oxide, hydrogen peroxide, malondialdehyde, and inflammatory cytokines TNF-α, IL-1β, and increased the levels of antioxidants superoxide dismutase, catalase, glutathione peroxidase, and anti-inflammatory cytokines IL-10 and TGF-β in vitro cell experiments. In vivo demyelination model, ICA significantly alleviated the behavioral abnormalities and enhanced the integrated optical density/mm

Identifiants

pubmed: 38177566
doi: 10.1007/s10787-023-01388-6
pii: 10.1007/s10787-023-01388-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Innovative Research Group Project of the National Natural Science Foundation of China
ID : 82004028

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Références

An J, Yin JJ, He Y, Sui RX, Miao Q, Wang Q, Yu JZ, Yu JW, Shi FD, Ma CG, Xiao BG (2020) Temporal and spatial dynamics of astroglial reaction and immune response in cuprizone-induced demyelination. Neurotox Res 37(3):587–601
pubmed: 31721051 doi: 10.1007/s12640-019-00129-4
Annibali V, Mechelli R, Romano S, Buscarinu MC, Fornasiero A, Umeton R, Ricigliano VA, Orzi F, Coccia EM, Salvetti M, Ristori G (2015) IFN-β and multiple sclerosis: from etiology to therapy and back. Cytokine Growth Factor Rev 26(2):221–228
pubmed: 25466632 doi: 10.1016/j.cytogfr.2014.10.010
Carrera-Juliá S, Moreno ML, Barrios C, de la Rubia Ortí JE, Drehmer E (2020) Antioxidant alternatives in the treatment of amyotrophic lateral sclerosis: a comprehensive review. Front Physiol 11:63
pubmed: 32116773 pmcid: 7016185 doi: 10.3389/fphys.2020.00063
Chesnokova V, Melmed S, Angeles CL, Angeles L (2014) Minireview: neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling. Molecules 143:1571–1574
Cho JH, Jung JY, Lee BJ, Lee K, Park JW, Bu Y (2017) Epimedii Herba: a promising herbal medicine for neuroplasticity. Phytother Res 31(6):838–848
pubmed: 28382688 doi: 10.1002/ptr.5807
Cong H, Zhang M, Chang H, Du L, Zhang X, Yin L (2020) Icariin ameliorates the progression of experimental autoimmune encephalomyelitis by down-regulating the major inflammatory signal pathways in a mouse relapse-remission model of multiple sclerosis. Eur J Pharmacol 885:173523
pubmed: 32871176 doi: 10.1016/j.ejphar.2020.173523
Davis KE, Burnett K, Gigg J (2017) Water and T-maze protocols are equally efficient methods to assess spatial memory in 3xTg Alzheimer’s disease mice. Behav Brain Res 331:54–66
pubmed: 28511979 doi: 10.1016/j.bbr.2017.05.005
Domingues HS, Portugal CC, Socodato R, Relvas JB (2016) Oligodendrocyte, astrocyte, and microglia crosstalk in myelin development, damage, and repair. Front Cell Dev Biol 4:71
pubmed: 27551677 pmcid: 4923166
Du Q, Xia M, Ito Y (2002) Purification of icariin from the extract of Epimedium segittatum using highspeed counter-current chromatography. J Chromatogr A. 962(1–2):239–241
Fernández J, Silván B, Entrialgo CR, Villar CJ, Capasso R, Uranga JA, Lombó F, Abalo R (2021) Antiproliferative and palliative activity of flavonoids in colorectal cancer. Biomed Pharmacother 143:112241
pubmed: 34649363 doi: 10.1016/j.biopha.2021.112241
Gingele S, Stangel M (2020) Emerging myelin repair agents in preclinical and early clinical development for the treatment of multiple sclerosis. Expert Opin Investig Drugs 29(6):583–594
pubmed: 32348161 doi: 10.1080/13543784.2020.1762567
Guo S, Wang H, Yin Y (2022) Microglia polarization from M1 to M2 in neurodegenerative diseases. Front Aging Neurosci 14:815347
pubmed: 35250543 pmcid: 8888930 doi: 10.3389/fnagi.2022.815347
Han SR, Kang YH, Jeon H, Lee S, Park SJ, Song DY, Min SS, Yoo SM, Lee MS, Lee SH (2020) Differential expression of miRNAs and behavioral change in the cuprizone-induced demyelination mouse model. Int J Mol Sci 21(2):646
pubmed: 31963761 pmcid: 7014274 doi: 10.3390/ijms21020646
Jin J, Wang H, Hua X, Chen D, Huang C, Chen Z (2019) An outline for the pharmacological effect of icariin in the nervous system. Eur J Pharmacol 842:20–32
pubmed: 30342950 doi: 10.1016/j.ejphar.2018.10.006
Kalafatakis I, Karagogeos D (2021) Oligodendrocytes and microglia: key players in myelin development. Damage Repair Biomol 11(7):1058
Kanno T, Kurotaki T, Yamada N, Tomonari Y, Sato J, Tsuchitani M, Kobayashi Y (2019) Supplemental study on 2’, 3’-cyclic nucleotide 3’-phosphodiesterase (CNPase) activity in developing rat spinal cord lesions induced by hexachlorophene and cuprizone. J Vet Med Sci 81(9):1368–1372
pubmed: 31447458 pmcid: 6785608 doi: 10.1292/jvms.19-0096
Kuhlmann T, Moccia M, Coetzee T, Cohen JA, Correale J, Graves J, Marrie RA, Montalban X, Yong VW, Thompson AJ, Reich DS (2023) Multiple sclerosis progression: time for a new mechanism-driven framework. Lancet Neurol 22(1):78–88
pubmed: 36410373 doi: 10.1016/S1474-4422(22)00289-7
Kwon HS, Koh SH (2020) Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener 9(1):42
pubmed: 33239064 pmcid: 7689983 doi: 10.1186/s40035-020-00221-2
Lan Z, Xie G, Wei M, Wang P, Chen L (2017) The protective effect of Epimedii Folium and Curculiginis Rhizoma on Alzheimer’s disease by the inhibitions of NF-κB/MAPK pathway and NLRP3 inflammasome. Oncotarget 8(27):43709–43720
pubmed: 28582770 pmcid: 5546435 doi: 10.18632/oncotarget.12574
Li C, Yang S, Ma H, Ruan M, Fang L, Cheng J (2021) Influence of icariin on inflammation, apoptosis, invasion, and tumor immunity in cervical cancer by reducing the TLR4/MyD88/NF-κB and Wnt/β-catenin pathways. Cancer Cell Int 21(1):206
pubmed: 33849528 pmcid: 8045342 doi: 10.1186/s12935-021-01910-2
Liu L, Locascio LM, Doré S (2019) Critical role of Nrf2 in experimental ischemic stroke. Front Pharmacol 10:153
pubmed: 30890934 pmcid: 6411824 doi: 10.3389/fphar.2019.00153
Luthra R, Roy A (2022) Role of medicinal plants against neurodegenerative diseases. Curr Pharm Biotechnol 23(1):123–139
pubmed: 33573549 doi: 10.2174/1389201022666210211123539
Masson MA, Nait-Oumesmar B (2023) Emerging concepts in oligodendrocyte and myelin formation, inputs from the zebrafish model. Glia 71(5):1147–1163
pubmed: 36645033 doi: 10.1002/glia.24336
Mitra S, Das R, Emran TB, Labib RK, Noor ET, Islam F, Sharma R, Ahmad I, Nainu F, Chidambaram K, Alhumaydhi FA, Chandran D, Capasso R, Wilairatana P (2022) Diallyl disulfide: a bioactive garlic compound with anticancer potential. Front Pharmacol 13:943967
pubmed: 36071845 pmcid: 9441672 doi: 10.3389/fphar.2022.943967
Mohajeri M, Sadeghizadeh M, Najafi F, Javan M (2015) Polymerized nano-curcumin attenuates neurological symptoms in EAE of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair. Neuropharmacol 99:156–167
doi: 10.1016/j.neuropharm.2015.07.013
Mojaverrostami S, Bojnordi MN, Ghasemi-Kasman M, Ebrahimzadeh MA, Hamidabadi HG (2018) A review of herbal therapy in multiple sclerosis. Adv Pharm Bull 8(4):575–590
pubmed: 30607330 pmcid: 6311642 doi: 10.15171/apb.2018.066
Ogata T (2019) Therapeutic strategies for oligodendrocyte-mediated remyelination. Adv Exp Med Biol 1190:265–279
pubmed: 31760650 doi: 10.1007/978-981-32-9636-7_17
Ohl K, Tenbrock K, Kipp M (2016) Oxidative stress in multiple sclerosis: central and peripheral mode of action. Exp Neurol 277:58–67
doi: 10.1016/j.expneurol.2015.11.010
Padmavathi G, Ramkumar KM (2021) MicroRNA mediated regulation of the major redox homeostasis switch, Nrf2, and its impact on oxidative stress-induced ischemic/reperfusion injury. Arch Biochem Biophys 698:108725
pubmed: 33326800 doi: 10.1016/j.abb.2020.108725
Park HA, Ellis AC (2020) Dietary antioxidants and Parkinson’s Disease. Antioxidants (Basel) 9(7):570
pubmed: 32630250 doi: 10.3390/antiox9070570
Pfeiffer SE, Barbarese E, Bhat S (1981) Noncoordinate regulation of myelinogenic parameters in primary cultures of dissociated fetal rat brain. J Neurosci Res 6(3):369–380
pubmed: 6170762 doi: 10.1002/jnr.490060312
Rudick RA, Rani MR, Xu Y, Lee JC, Na J, Shrock J, Josyula A, Fisher E, Ransohoff RM (2011) Excessive biologic response to IFNβ is associated with poor treatment response in patients with multiple sclerosis. PLoS ONE 6(5):e19262
pubmed: 21602934 pmcid: 3094352 doi: 10.1371/journal.pone.0019262
Sams EC (2021) Oligodendrocytes in the aging brain. Neuronal Signal 5(3):NS20210008
pubmed: 34290887 pmcid: 8264650 doi: 10.1042/NS20210008
Sen MK, Mahns DA, Coorssen JR, Shortland PJ (2019) Behavioural phenotypes in the cuprizone model of central nervous system demyelination. Neurosci Biobehav Rev 107:23–46
pubmed: 31442519 doi: 10.1016/j.neubiorev.2019.08.008
Sen MK, Almuslehi MSM, Coorssen JR, Mahns DA, Shortland PJ (2020) Behavioural and histological changes in cuprizone-fed mice. Brain Behav Immun 87:508–523
pubmed: 32014578 doi: 10.1016/j.bbi.2020.01.021
Shen R, Deng W, Li C, Zeng G (2015) A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis. Int Immunopharmacol 24(2):224–231
pubmed: 25528476 doi: 10.1016/j.intimp.2014.12.015
Singh S, Metz I, Amor S, van der Valk P, Stadelmann C, Brück W (2013) Microglial nodules in early white matter are associated with degenerating axons. Acta Neuropathol 125(4):595–608
pubmed: 23354834 pmcid: 3611040 doi: 10.1007/s00401-013-1082-0
Sivandzade F, Prasad S, Bhalerao A, Cucullo L (2019) NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches. Redox Biol 21:101059
pubmed: 30576920 doi: 10.1016/j.redox.2018.11.017
Stangel M, Kuhlmann T, Matthews PM, Kilpatrick TJ (2017) Achievements and obstacles of remyelinating therapies in multiple sclerosis. Nat Rev Neurol 13(12):742–754
pubmed: 29146953 doi: 10.1038/nrneurol.2017.139
Stark JC, Wallace E, Lim R, Leaw B (2018) Characterization and isolation of mouse primary microglia by density gradient centrifugation. J vis Exp 132:57065
Steelman AJ, Thompson JP, Li J (2012) Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication. Neurosci Res 72(1):32–42
pubmed: 22015947 doi: 10.1016/j.neures.2011.10.002
Sze SC, Tong Y, Ng TB, Cheng CL, Cheung HP (2010) Herba Epimedii: anti-oxidative properties and its medical implications. Molecules 15(11):7861-7870
pubmed: 21060294 pmcid: 6259234 doi: 10.3390/molecules15117861
Tamashiro TT, Dalgard CL, Byrnes KR (2012) Primary microglia isolation from mixed glial cell cultures of neonatal rat brain tissue. J Vis Exp 66:e3814
Tan J, Li W, Teng Z, Wang G, Li Y, Zhang Y. Kaohsiung J (2022) Senkyunolide H inhibits activation of microglia and attenuates lipopolysaccharide-mediated neuroinflammation and oxidative stress in BV2 microglia cells via regulating ERK and NF-κB pathway. Med Sci. 38(4):378–384
Teleanu DM, Niculescu AG, Lungu II, Radu CI, Vladâcenco O, Roza E, Costăchescu B, Grumezescu AM, Teleanu RI (2022) An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. Int J Mol Sci 23(11):5938
pubmed: 35682615 pmcid: 9180653 doi: 10.3390/ijms23115938
Thapa A, Carroll NJ (2017) Dietary modulation of oxidative stress in Alzheimer’s Disease. Int J Mol Sci 18(7):1583
pubmed: 28753984 pmcid: 5536070 doi: 10.3390/ijms18071583
Tian H, Ding N, Guo M, Wang S, Wang Z, Liu H, Yang J, Li Y, Ren J, Jiang J, Li Z (2019) Analysis of learning and memory ability in an Alzheimer’s disease mouse model using the Morris water maze. J Vis Exp. https://doi.org/10.3791/60055
doi: 10.3791/60055 pubmed: 31736488
Tuoheti A, Gu X, Cheng X, Zhang H (2021) Silencing Nrf2 attenuates chronic suppurative otitis media by inhibiting pro-inflammatory cytokine secretion through up-regulating TLR4. Innate Immun 27(1):70–80
pubmed: 32579053 doi: 10.1177/1753425920933661
Wang Y, Shang C, Zhang Y, Xin L, Jiao L, Xiang M, Shen Z, Chen C, Ding F, Lu Y, Cui X (2023) Regulatory mechanism of icariin in cardiovascular and neurological diseases. Biomed Pharmacother 158:114156
pubmed: 36584431 doi: 10.1016/j.biopha.2022.114156
Waslo C, Bourdette D, Gray N, Wright K, Spain R (2019) Lipoic acid and other antioxidants as therapies for multiple sclerosis. Curr Treat Options Neurol 21(6):26
pubmed: 31056714 doi: 10.1007/s11940-019-0566-1
Wei Z, Deng X, Hong M, Su Q, Liu A, Huang Y, Yu Q, Peng Z (2015) Icariin has synergistic effects with methylprednisolone to ameliorate EAE via modulating HPA function, promoting anti-inflammatory and anti-apoptotic effects. Int J Clin Exp Med 8(11):20188–20197
pubmed: 26884931 pmcid: 4723776
Wei Z, Wang M, Hong M, Diao S, Liu A, Huang Y, Yu Q, Peng Z (2016) Icariin exerts estrogen-like activity in ameliorating EAE via mediating estrogen receptorβ, modulating HPA function and glucocorticoid receptor expression. Am J Transl Res 8(4):1910–1918
pubmed: 27186315 pmcid: 4859920
Yankelevitch-Yahav R, Franko M, Huly A, Doron R (2015) The forced swim test as a model of depressive-like behavior. J vis Exp 97:52587
Zhang B, Wang G, He J, Yang Q, Li D, Li J, Zhang F (2019) Icariin attenuates neuroinflammation and exerts dopamine neuroprotection via a Nrf2-dependent manner. J Neuroinflammation 16(1):92
pubmed: 31010422 pmcid: 6477740 doi: 10.1186/s12974-019-1472-x
Zhen W, Liu A, Lu J, Zhang W, Tattersall D, Wang J (2017) An alternative cuprizone-induced demyelination and remyelination mouse model. ASN Neuro 9(4):1759091417725174
pubmed: 28840755 pmcid: 5574485 doi: 10.1177/1759091417725174
Zheng XX, Li YC, Yang KL, He ZX, Wang ZL, Wang X, Jing HL, Cao YJ (2021) Icariin reduces Glu-induced excitatory neurotoxicity via antioxidative and antiapoptotic pathways in SH-SY5Y cells. Phytother Res 35(6):3377–3389
pubmed: 33891785 doi: 10.1002/ptr.7057
Zirngibl M, Assinck P, Sizov A, Caprariello AV, Plemel JR (2022) Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination. Mol Neurodegener 17(1):34
pubmed: 35526004 pmcid: 9077942 doi: 10.1186/s13024-022-00538-8

Auteurs

Li-Juan Song (LJ)

The Key Research Laboratory of Benefiting Qi for Acting Blood Circulation Method to Treat Multiple Sclerosis of State Administration of Traditional Chinese Medicine, Shanxi University of Chinese Medicine, Taiyuan, China.
Department of Neurosurgery, Sinopharm Tongmei General Hospital, Datong, China.

Qing-Xian Han (QX)

The Key Research Laboratory of Benefiting Qi for Acting Blood Circulation Method to Treat Multiple Sclerosis of State Administration of Traditional Chinese Medicine, Shanxi University of Chinese Medicine, Taiyuan, China.

Zhi-Bin Ding (ZB)

The Key Research Laboratory of Benefiting Qi for Acting Blood Circulation Method to Treat Multiple Sclerosis of State Administration of Traditional Chinese Medicine, Shanxi University of Chinese Medicine, Taiyuan, China.

Kexin Liu (K)

The Key Research Laboratory of Benefiting Qi for Acting Blood Circulation Method to Treat Multiple Sclerosis of State Administration of Traditional Chinese Medicine, Shanxi University of Chinese Medicine, Taiyuan, China.

Xiao-Xu Zhang (XX)

Department of Neurosurgery, Sinopharm Tongmei General Hospital, Datong, China.

Min-Fang Guo (MF)

Institute of Brain Science, Shanxi Datong University, Datong, China.

Dong Ma (D)

Department of Neurosurgery, Sinopharm Tongmei General Hospital, Datong, China.

Qing Wang (Q)

The Key Research Laboratory of Benefiting Qi for Acting Blood Circulation Method to Treat Multiple Sclerosis of State Administration of Traditional Chinese Medicine, Shanxi University of Chinese Medicine, Taiyuan, China. 4024771456@163.com.

Bao-Guo Xiao (BG)

Institute of Neurology, Huashan Hospital, Institutes of Brain Science and State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China. bgxiao@shmu.edu.cn.

Cun-Gen Ma (CG)

The Key Research Laboratory of Benefiting Qi for Acting Blood Circulation Method to Treat Multiple Sclerosis of State Administration of Traditional Chinese Medicine, Shanxi University of Chinese Medicine, Taiyuan, China. macungen@sxtcm.edu.cn.
Institute of Brain Science, Shanxi Datong University, Datong, China. macungen@sxtcm.edu.cn.

Classifications MeSH